- Entry
- $13.30
- Now
- $12.70 -4.5%
- Target
- —
- Score
- —
This one is probably worth keeping an eye on... again TLDR for those not following it. A couple months ago, SLS announced they were at 78 of the required 80 events for their Regal trial for a product called GPS which is used to treat AML. TAM for AML will depend on approval. Approval for CR1 and CR2 is likely a 4-5B TAM, CR2 only is more in the 1-2B range. The trial itself was derisked by an interim analysis …
— ORIGINAL POST ·
SLS looking like it may squeeze again
· r/Shortsqueeze
· Jun 19, 2026